What You Need to Know About De Novo MBC Research - Metastatic Breast Cancer Trial Talk

Research News

Metastatic breast cancer (MBC) is most often diagnosed in people who were previously treated for early-stage breast cancer, months, years, or even decades ago. This is called “recurrent MBC”. However, sometimes breast cancer is first diagnosed as metastatic (stage IV), meaning that breast cancer has already spread to other parts of the body, often the bones, brain, liver, or lungs. This is called “de novo MBC”. Because de novo MBC has not been treated with any breast cancer drugs, the cancer cells generally respond better to treatment than recurrent MBC. As a result, people with de novo MBC generally have better outcomes than people with recurrent MBC.

Clinical trials and other research are studying ways to treat de novo MBC. Read the links below to learn more about de novo MBC research and how to find MBC clinical trials.

Introduction to De Novo MBC
Surgery to Remove the Breast Tumor for De Novo MBC
De Novo MBC and Brain Metastasis
imC Clinical Trials

Last Modified on July 1, 2024



for past articles or specific information.